January 1, 2003

Clinical Applications of Recombinant Human BMPS

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Corresponding author: Thomas A. Einhorn, MD, Department of Orthopaedic Surgery, Boston University Medical Center, 720 Harrison Avenue, Suite 808, Boston, MA 02118. E-mail address: email protected

Preguntar a la IA

Me gusta

Guardar

Cite This Study

Thomas A. Einhorn (Wed,) studied this question.

synapsesocial.com/papers/6a0b866b5f2af8d200c1f91d https://doi.org/https://doi.org/10.2106/00004623-200300003-00014

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Morbidity at Bone Graft Donor Sites1989 · 2,011 citations
2Repair of segmental defects of the tibia with cancellous bone grafts augmented with human bone morphogenetic protein. A preliminary report.1988 · 144 citations
3Distal metaphyseal tibial nonunion. Deformity and bone loss treated by open reduction, internal fixation, and human bone morphogenetic protein (hBMP).1990 · 127 citations
4The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats.1992 · 666 citations
5Healing Segmental Femoral Defects in Sheep Using Recombinant Human Bone Morphogenetic Protein1993 · 309 citations

Preguntar a la IA

Me gusta

Guardar